RIM
MED icon

Redwood Investment Management’s Medifast MED Stock Holding History

Redwood Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,252
Closed -$226K – 257
2022
Q2 		$226K Sell
1,252
-60
-5% -$10.7K 0.04% 220
2022
Q1 		$224K Buy
+1,312
New +$247K 0.03% 257
2020
Q3 		– Sell
-7,331
Closed -$1.02M – 276
2020
Q2 		$1.02M Sell
7,331
-5,843
-44% -$536K 0.29% 40
2020
Q1 		$823K Buy
13,174
+2,161
+20% +$197K 0.52% 28
2019
Q4 		$1.21M Buy
+11,013
New +$1.07M 0.3% 58

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Redwood Investment Management's MED Position: Q3 2022 in Review

Redwood Investment Management sold out of Medifast (MED) in Q3 2022, closing a stake of 1,252 shares — an estimated $226K sold.

Redwood Investment Management first reported a position in MED in Q4 2019 and held it in 5 quarters. The position peaked at $1.21M in Q4 2019. 264 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Redwood Investment Management reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Redwood Investment Management sold 1,252 Medifast shares in Q3 2022, an estimated $226K.
  • Redwood Investment Management first reported a position in Medifast in Q4 2019 and held it in 5 quarters.
  • Redwood Investment Management's Medifast position peaked at $1.21M in Q4 2019.
  • 264 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Redwood Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.